Evidence map›Paper›PMID 29364340›Full record

Trial reportJournal of applied oral science : revista FOB2018

Microbiological and clinical effects of probiotics and antibiotics on nonsurgical treatment of chronic periodontitis: a randomized placebo- controlled trial with 9-month follow-up.

Alicia Morales, Alessandro Gandolfo, Joel Bravo, Paola Carvajal, Nora Silva, Claudia Godoy, Jocelyn Garcia-Sesnich, Anilei Hoare, Patricia Diaz, Jorge Gamonal

2 registry-linked trialsOpen access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of applied oral science : revista FOB, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 45 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 7 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04209777 phase3completednot on this map

Clinical Evaluation of Smoker Periodontal Subjects After Lactobacillus-reuteri Probiotics and Antibiotics Therapy With Scaling and Root Debridement: a Clinical Trial

TypeinterventionalSponsorDow University of Health SciencesRan2018 to 2019Enrolled66ConditionsPeriodontal Diseases, SmokingArmsProbiotic Blend Chewable Tablet, Antibiotics
NCT06063226 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Clinical and Microbiological Aspects of Probiotics in Non-surgical Periodontal Therapy: a Randomized Controlled Trial.

TypeinterventionalSponsorG. d'Annunzio UniversityRan2023 to 2024Enrolled70ConditionsPeriodontitis, Probiotics, Non Surgical Periodontal TherapyArmsExperimental, Negative control, Positive control
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 7 syntheses or guidelines pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Oral Supplementation ofDentistry journal · 2026
    Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. The impact of prebiotics and probiotics on the oral microbiome of individuals with periodontal disease: a scoping review.Canadian journal of dental hygiene : CJDH = Journal canadien de l'hygiene dentaire : JCHD · 2024
    Article
  19. Review
  20. Effect of ProbioticsDentistry journal · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Alicia MoralesUniversidad de Chile, Facultad de Odontología, Departamento de Odontología Conservadora, Laboratorio de Biología Periodontal, Chile.
Alessandro GandolfoUniversidad de Chile, Facultad de Odontología, Departamento de Odontología Conservadora, Laboratorio de Biología Periodontal, Chile.
Joel BravoUniversidad de Antofagasta, Facultad de Odontología, Departamento de Odontología, Chile.
Paola CarvajalUniversidad de Chile, Facultad de Odontología, Departamento de Odontología Conservadora, Laboratorio de Biología Periodontal, Chile.
Nora SilvaUniversidad de Chile, Facultad de Odontología, Departamento de Medicina y Patología Oral, Laboratorio de Microbiología, Chile.
Claudia GodoyUniversidad de Chile, Facultad de Odontología, Departamento de Odontología Conservadora, Laboratorio de Biología Periodontal, Chile.
Jocelyn Garcia-SesnichUniversidad de Chile, Facultad de Odontología, Departamento de Odontología Conservadora, Laboratorio de Biología Periodontal, Chile.
Anilei HoareDivision of Periodontology, Department of Oral Health and Diagnostic Sciences, The University of Connecticut Health Center, Farmington, Connecticut, United States of America.
Patricia DiazDivision of Periodontology, Department of Oral Health and Diagnostic Sciences, The University of Connecticut Health Center, Farmington, Connecticut, United States of America.
Jorge GamonalUniversidad de Chile, Facultad de Odontología, Departamento de Odontología Conservadora, Laboratorio de Biología Periodontal, Chile.
University of Chile · CLUConn Health · USUniversity of Antofagasta · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this double-blind, placebo-controlled and parallel- arm randomized clinical trial was to evaluate the effects of Lactobacillus rhamnosus SP1-containing probiotic sachet and azithromycin tablets as an adjunct to nonsurgical therapy in clinical parameters and in presence and levels of Tannerella forsythia, Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. Forty-seven systemically healthy volunteers with chronic periodontitis were recruited and monitored clinically and microbiologically at baseline for 3, 6 and 9 months after therapy. Subgingival plaque samples were collected from four periodontal sites with clinical attachment level ≥1 mm, probing pocket depth ≥4 mm and bleeding on probing, one site in each quadrant. Samples were cultivated and processed using the PCR technique. Patients received nonsurgical therapy including scaling and root planing (SRP) and were randomly assigned to a probiotic (n=16), antibiotic (n = 16) or placebo (n = 15) group. L. rhamnosus SP1 was taken once a day for 3 months. Azithromycin 500mg was taken once a day for 5 days. All groups showed improvements in clinical and microbiological parameters at all time points evaluated. Probiotic and antibiotic groups showed greater reductions in cultivable microbiota compared with baseline. The placebo group showed greater reduction in number of subjects with P. gingivalis compared with baseline. However, there were no significant differences between groups. The adjunctive use of L. rhamnosus SP1 sachets and azithromycin during initial therapy resulted in similar clinical and microbiological improvements compared with the placebo group.

Indexed as

AdultAggregatibacter actinomycetemcomitansAnalysis of VarianceAnti-Bacterial AgentsAzithromycinChronic PeriodontitisColony Count, MicrobialDental PlaqueDental ScalingDouble-Blind MethodFemaleHumansLacticaseibacillus rhamnosusMaleMiddle AgedPeriodontal IndexAnti-Bacterial AgentsAzithromycin

Identifiers

PMID29364340
PMCPMC5777419
OpenAlexW2783179171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.